Isthmus Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-111
Closed -$6K 166
2021
Q2
$6K Buy
+111
New +$6.49K ﹤0.01% 248
2018
Q4
Sell
-111
Closed -$6K 157
2018
Q3
$6K Hold
111
﹤0.01% 259
2018
Q2
$5K Hold
111
﹤0.01% 248
2018
Q1
$7K Hold
111
﹤0.01% 238
2017
Q4
$7K Hold
111
﹤0.01% 248
2017
Q3
$7K Hold
111
﹤0.01% 253
2017
Q2
$9K Hold
111
﹤0.01% 255
2017
Q1
$9K Hold
111
﹤0.01% 261
2016
Q4
$8K Hold
111
﹤0.01% 266
2016
Q3
$8K Hold
111
﹤0.01% 248
2016
Q2
$9K Hold
111
﹤0.01% 227
2016
Q1
$9K Hold
111
﹤0.01% 229
2015
Q4
$10K Hold
111
﹤0.01% 234
2015
Q3
$9K Hold
111
﹤0.01% 248
2015
Q2
$9K Hold
111
﹤0.01% 248
2015
Q1
$10K Hold
111
﹤0.01% 238
2014
Q4
$9K Buy
+111
New +$8.77K ﹤0.01% 243

Other funds holding CAH

Isthmus Partners's CAH Position: Q3 2021 in Review

Isthmus Partners sold out of Cardinal Health (CAH) in Q3 2021, closing a stake of 111 shares — an estimated $6K sold.

Isthmus Partners first reported a position in CAH in Q4 2014 and held it in 17 quarters. The position peaked at $10K in Q4 2015. 750 funds tracked by Wall St. Rank hold CAH as of Q3 2021.

  • Isthmus Partners reported no remaining Cardinal Health position as of Q3 2021 after selling out during the quarter.
  • Isthmus Partners sold 111 Cardinal Health shares in Q3 2021, an estimated $6K.
  • Isthmus Partners first reported a position in Cardinal Health in Q4 2014 and held it in 17 quarters.
  • Isthmus Partners's Cardinal Health position peaked at $10K in Q4 2015.
  • 750 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.

Based on Isthmus Partners's 13F filing for Q3 2021, filed 10 Nov 2021.